YEL068C Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to YEL068C Antibody

YEL068C Antibody is a polyclonal antibody targeting the YEL068C protein encoded by the YEL068C gene in Saccharomyces cerevisiae (Baker’s yeast). This antibody is validated for use in research applications such as immunoblotting, immunofluorescence, and chromatin immunoprecipitation (ChIP) to study protein localization, interactions, and genomic stability mechanisms .

Research Applications

YEL068C Antibody is primarily employed in studies investigating:

  • Genomic Instability: The YEL068c locus is used as a marker in gross chromosomal rearrangement (GCR) assays to quantify mutation rates and DNA repair efficiency .

  • Replication Stress: This antibody aids in detecting protein interactions involved in DNA replication fork progression and checkpoint activation .

  • Epigenetic Regulation: YEL068C’s role in chromatin organization and transcriptional silencing has been explored using ChIP assays .

Role in DNA Damage Response

Studies using YEL068C Antibody revealed that deletion of YEL068C increases GCR rates by 10–20 fold in yeast, highlighting its role in maintaining genomic stability . This aligns with its interaction with replication stress sensors like Rad53 and Ddc1 .

Functional Insights

  • Mutation Rate Analysis: In GCR assays, loss of the URA3 and CAN1 markers at the YEL068c locus is quantified using selective media (e.g., 5-FOA + canavanine) . The formula for calculating GCR rates is:

    m[1.24+ln(m)]=NFCNTm[1.24 + \ln(m)] = \frac{N_{\text{FC}}}{N_{\text{T}}}

    Here, mm = mutational events, NFCN_{\text{FC}} = colonies on selective media, and NTN_{\text{T}} = total colonies .

  • Protein Interactions: Co-immunoprecipitation experiments with YEL068C Antibody identified its association with replication machinery components, including Pol2 and Mrc1 .

Validation and Quality Control

  • Specificity: Validated using S. cerevisiae lysates in Western blotting, showing a single band at the predicted molecular weight (~45 kDa) .

  • Cross-Reactivity: No observed reactivity with human or bacterial proteins .

Comparative Insights

While YEL068C Antibody is specific to yeast, analogous antibodies targeting human homologs (e.g., BRAF V600E monoclonal antibodies) demonstrate the broader utility of epitope-specific reagents in translational research .

Limitations and Future Directions

Current limitations include restricted species reactivity and a lack of commercial conjugates (e.g., fluorescent tags). Future studies could explore engineered variants for live-cell imaging or high-throughput screening.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YEL068C antibody; Uncharacterized protein YEL068C antibody
Target Names
YEL068C
Uniprot No.

Q&A

What is YEL068C and why is it significant in yeast research?

YEL068C is a genetic locus in Saccharomyces cerevisiae (baker's yeast) that has been used as an insertion site for experimental cassettes in genomic instability research. The URA3-CAN1 cassette is frequently inserted at this locus for gross chromosomal rearrangement (GCR) assays, making it an important site for studying DNA replication and repair mechanisms . Antibodies targeting proteins expressed from or associated with this locus would be valuable for researchers investigating replication dynamics and genomic stability.

How do I select the appropriate YEL068C antibody for my research?

When selecting a YEL068C antibody, consider the specific experimental application (Western blot, immunoprecipitation, immunofluorescence), the host species, and validation data availability. As with other yeast protein antibodies, refer to antibody data repositories that share validation data for specific applications . For yeast proteins like those associated with YEL068C, check whether the antibody has been validated in wild-type versus knockout strains to confirm specificity. Additionally, review the clonality (monoclonal versus polyclonal) based on your experimental needs for specificity versus epitope coverage.

What controls should I include when using YEL068C antibody?

Essential controls include:

  • Negative control: YEL068C deletion strain lysates to confirm antibody specificity

  • Loading control: Anti-β-tubulin antibody (similar to what's mentioned in search result )

  • Technical controls: Secondary antibody-only samples to assess non-specific binding

  • Positive control: If studying in the context of DNA replication, include controls for known replication factors (like those in the CMG complex mentioned in the search results)

What is the optimal protocol for Western blotting with YEL068C antibody?

Based on standard protocols for yeast proteins:

  • Extract proteins using bead-beating in an appropriate lysis buffer (similar to the one described in search result : "50 mM HEPES-KOH pH 7.5, 140 mM sodium chloride, 1% Triton X-100, 2 mM magnesium chloride, with protease inhibitors")

  • Separate proteins by SDS-PAGE and transfer to nitrocellulose membrane

  • Block with 5% BSA or non-fat milk in TBST

  • Incubate with primary YEL068C antibody (typically 1:1000 dilution) overnight at 4°C

  • Wash with TBST (3-5 times for 5 minutes each)

  • Incubate with appropriate secondary antibody (1:5000-1:10000) for 1 hour at room temperature

  • Wash and develop using chemiluminescent detection

This approach is consistent with the Western blotting procedures described for other yeast proteins in the search results .

How can I optimize co-immunoprecipitation experiments with YEL068C antibody?

For optimal co-immunoprecipitation results:

  • Lyse cells in a buffer that preserves protein-protein interactions while effectively extracting proteins of interest (reference the co-IP buffer from search result )

  • Pre-clear lysate with Protein G beads to reduce non-specific binding

  • Incubate cleared lysate with YEL068C antibody (approximately 2-5 μg per 1 mg of protein) for 3 hours at 4°C

  • Add fresh Protein G beads and incubate for an additional 1 hour

  • Wash beads thoroughly (4-5 times) with lysis buffer containing reduced detergent

  • Elute bound proteins with 2× Laemmli buffer without DTT as described in the methods

  • Analyze by Western blotting with antibodies against suspected interaction partners

How do I design experiments to study YEL068C in the context of DNA replication?

To investigate YEL068C in relation to DNA replication:

  • Synchronize yeast cells in G1 phase using alpha-factor (5 μg/ml) until >90% arrest is achieved

  • Release cells into S phase by washing and resuspending in fresh medium

  • Collect samples at various time points (e.g., 0, 20, 40, 60, and 80 minutes post-release)

  • Process samples for flow cytometry to track S phase progression

  • In parallel, prepare protein extracts for Western blotting with YEL068C antibody

  • Consider performing 2D gel electrophoresis to analyze replication intermediates at origins like ARS305 and ARS1212

  • Use co-immunoprecipitation to assess interactions with replication factors such as components of the CMG complex

This experimental design follows approaches used for studying replication factors in yeast as described in the search results .

How can I use YEL068C antibody to study genomic instability mechanisms?

For investigating genomic instability:

  • Establish strains with the URA3-CAN1 cassette inserted at YEL068C as described in search result

  • Perform Gross Chromosomal Rearrangement (GCR) assays by plating cells on SC + 5-FOA + canavanine (FC) and YPD plates

  • Calculate GCR rates using the formula: m/NT, where m(1.24 + ln[m]) - NFC = 0

  • In parallel, use YEL068C antibody to track protein expression and modification status during genomic instability events

  • Combine with chromatin immunoprecipitation (ChIP) to identify genomic binding sites

  • Correlate protein levels or modifications with mutation rates to establish functional relationships

What approaches can I use to study protein-DNA interactions involving YEL068C?

To analyze protein-DNA interactions:

  • Perform electrophoretic mobility shift assays (EMSA) with purified protein and labeled DNA substrates

  • Titrate protein concentration (e.g., 1, 2, 5, 7.5, and 10 nM) against a fixed DNA concentration (e.g., 25 nM)

  • Conduct binding reactions in appropriate buffer (e.g., "20 mM HEPES (pH 7.6), 10% glycerol, 2 mM EDTA, 2 mM DTT, 0.2 mg ml^-1 BSA, and 0.02% NP-40")

  • Resolve protein-DNA complexes by native polyacrylamide gel electrophoresis

  • Quantify using fluorescence imaging systems

  • Compare binding affinities and patterns between wild-type and mutant proteins to assess functional significance

How can I integrate YEL068C antibody studies with replication fork progression analysis?

For comprehensive replication fork studies:

  • Use two-dimensional agarose gel electrophoresis to analyze replication intermediates

  • Compare patterns of bubble-shaped and Y-shaped intermediates at early and late origins

  • Quantify the percentage of different replication intermediate structures

  • In parallel, use YEL068C antibody for Western blotting and ChIP analysis at different time points during S phase

  • Compare replication patterns between wild-type and mutant strains

  • Correlate protein localization data with replication fork progression or stalling events

  • Assess the impact of replication stress (e.g., hydroxyurea treatment) on protein dynamics

What might cause inconsistent YEL068C antibody signal in Western blots?

Several factors can contribute to inconsistent signals:

  • Protein extraction efficiency: Ensure consistent cell lysis by standardizing bead-beating time and buffer composition

  • Protein degradation: Add complete protease inhibitor cocktail to all buffers (e.g., "1× protease inhibitor cocktail (APExBIO, Cat. # K1009)")

  • Transfer efficiency: Validate transfer by using stained protein ladders and Ponceau S staining

  • Antibody quality: Aliquot antibodies to avoid freeze-thaw cycles and store at recommended temperatures

  • Detection sensitivity: Optimize exposure times and consider using more sensitive detection methods for low-abundance proteins

How do I interpret contradictory results between YEL068C antibody detection and genetic data?

When facing contradictory results:

  • Verify antibody specificity using knockout controls

  • Consider post-translational modifications that might affect epitope recognition

  • Assess whether the protein might be functioning in a complex where epitopes are masked

  • Evaluate the possibility of alternative splicing or processing affecting the detected protein species

  • Design experiments to test specific hypotheses about the contradiction, such as:

    • Does the protein level correlate with activity?

    • Are there compensatory mechanisms at play?

    • Could the timing of protein expression versus genetic effects explain the discrepancy?

How can I quantitatively analyze YEL068C protein levels across different experimental conditions?

For rigorous quantitative analysis:

  • Include a standard curve of recombinant protein or serial dilutions of a reference sample

  • Use appropriate loading controls (e.g., β-Tubulin as mentioned in search result )

  • Capture images within the linear range of detection

  • Normalize YEL068C signal to loading control signal using densitometry software

  • Perform statistical analysis across biological replicates (minimum of three)

  • Consider using mass spectrometry-based approaches for absolute quantification

  • For time-course experiments, express data as fold-change relative to time zero or appropriate reference point

What are the relative advantages of different immunodetection methods for YEL068C protein?

Table 1: Comparative Analysis of YEL068C Detection Methods

MethodSensitivitySpecificityQuantificationSpatial InformationTechnical Complexity
Western BlotMediumHighSemi-quantitativeNoneModerate
ImmunoprecipitationHighMedium-HighLowNoneHigh
ChIPMediumMedium-HighSemi-quantitativeGenomic locationHigh
ImmunofluorescenceLow-MediumVariableLowSubcellular localizationModerate
Mass SpectrometryHighVery HighQuantitativeNoneVery High

How should I validate a new YEL068C antibody for my specific application?

For comprehensive antibody validation:

  • Test antibody with positive and negative controls (wild-type vs. deletion strains)

  • Perform peptide competition assays to confirm epitope specificity

  • Compare results across different applications (Western blot, IP, IF)

  • Validate against tagged versions of the protein if available

  • Consider cross-validation with multiple antibodies targeting different epitopes

  • Document all validation data according to antibody reporting standards

  • Submit validation data to antibody repositories to benefit the research community

How can I interpret YEL068C protein dynamics during cell cycle progression?

Table 2: Expected YEL068C Protein Behavior During Cell Cycle Phases

Cell Cycle PhaseExpected Protein LevelPotential ModificationsTypical Cellular LocalizationFunctional Significance
G1BaselineMinimal phosphorylationPrimarily nuclearPreparation for replication
SElevatedIncreased phosphorylationAt replication forksActive in DNA synthesis
G2DecreasingDephosphorylation beginningDiffuse nuclearPost-replication roles
MLowPossibly ubiquitinatedExcluded from condensed chromatinRegulatory turnover

This interpretation framework is based on the cell cycle analysis protocols and replication protein dynamics described in search result .

What factors should I consider when analyzing YEL068C in the context of replication stress?

When studying replication stress responses:

  • Monitor both total protein levels and post-translational modifications

  • Track changes in protein-protein interactions, particularly with checkpoint proteins like Rad53

  • Assess chromatin association patterns before and after stress induction

  • Compare wild-type responses to those in checkpoint-deficient backgrounds

  • Evaluate correlation between YEL068C protein dynamics and replication fork progression

  • Consider the timing of events in relation to checkpoint activation

  • Analyze potential colocalization with markers of stalled replication forks

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.